gene_id,gene_symbol,name,in_manning,in_kinmap,in_uniprot_kinasedomain,in_IDG_darkkinases,n_pubmed_citations_2013to2018,pharos_designation,PDB,title,expMethod,deposition_date,last_modification_date,resolution,InChI,InChIKey,chemicalName,smiles,formula,molecularWeight
9020,MAP3K14,mitogen-activated protein kinase kinase kinase 14,1,1,1,1,39,Tchem,4IDT,"Crystal Structure of NIK with 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine (T28)",X-RAY DIFFRACTION,2012-12-13,2013-04-17,2.4,"InChI=1S/C15H13BrN4/c16-9-4-5-11-10(6-9)13-12(19-11)3-1-2-8-7-18-15(17)20-14(8)13/h4-7,19H,1-3H2,(H2,17,18,20)",MEOWHQIIZUZBTO-UHFFFAOYSA-N,"11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine",c1cc2c(cc1Br)c-3c([nH]2)CCCc4c3nc(nc4)N,C15 H13 Br N4,329.195
9020,MAP3K14,mitogen-activated protein kinase kinase kinase 14,1,1,1,1,39,Tchem,4DN5,Crystal Structure of NF-kB-inducing Kinase (NIK),X-RAY DIFFRACTION,2012-02-08,2013-07-17,2.5,"InChI=1S/C10H16N5O12P3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(25-10)1-24-28(18,19)26-29(20,21)27-30(22,23)31/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H,20,21)(H2,11,12,13)(H2,22,23,31)/t4-,6-,7-,10-/m1/s1;InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2;InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2;InChI=1S/Mg/q+2",NLTUCYMLOPLUHL-KQYNXXCUSA-N;LYCAIKOWRPUZTN-UHFFFAOYSA-N;PEDCQBHIVMGVHV-UHFFFAOYSA-N;JLVVSXFLKOJNIY-UHFFFAOYSA-N,"PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER;1,2-ETHANEDIOL;GLYCEROL;MAGNESIUM ION",c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O)N;C(CO)O;C(C(CO)O)O;[Mg+2],C10 H16 N5 O12 P3 S;C2 H6 O2;C3 H8 O3;Mg 2,523.247;62.068;92.094;24.305
9020,MAP3K14,mitogen-activated protein kinase kinase kinase 14,1,1,1,1,39,Tchem,4G3D,Crystal structure of human NF-kappaB inducing kinase (NIK),X-RAY DIFFRACTION,2012-07-13,2018-01-24,2.9,InChI=1S/Mg/q+2,JLVVSXFLKOJNIY-UHFFFAOYSA-N,MAGNESIUM ION,[Mg+2],Mg 2,24.305
9020,MAP3K14,mitogen-activated protein kinase kinase kinase 14,1,1,1,1,39,Tchem,4IDV,Crystal Structure of NIK with compound 4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1H-indol-5-yl}-2-methylbut-3-yn-2-ol (13V),X-RAY DIFFRACTION,2012-12-13,2013-04-17,2.9,"InChI=1S/C20H22N4O3/c1-20(2,25)7-6-13-4-5-16-14(10-13)15(11-22-16)18-17(27-9-8-26-3)12-23-19(21)24-18/h4-5,10-12,22,25H,8-9H2,1-3H3,(H2,21,23,24)",ZZIZLABGKZWVAW-UHFFFAOYSA-N,4-{3-[2-amino-5-(2-methoxyethoxy)pyrimidin-4-yl]-1H-indol-5-yl}-2-methylbut-3-yn-2-ol,CC(C)(C#Cc1ccc2c(c1)c(c[nH]2)c3c(cnc(n3)N)OCCOC)O,C20 H22 N4 O3,366.414
